News
-
-
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Eckert & Ziegler Subsidiary Pentixapharm Receives Encouraging FDA Feedback to Initiate Phase III Trial with PentixaFor as Radiopharmaceutical Diagnostic in Primary Aldosteronism
Pentixapharm, a subsidiary of Eckert & Ziegler SE, receives FDA feedback to start Phase III trial with radiopharmaceutical diagnostic Ga68-PentixaFor for Primary Aldosteronism -